$0 is the total value of Canaan Partners IX LLC's 1 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | Sell | Arvinas Inc | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arvinas Inc | 11 | Q2 2022 | 100.0% |
| CytomX Therapeutics, Inc. | 4 | Q3 2016 | 100.0% |
| The RealReal Inc | 3 | Q2 2020 | 47.4% |
| LIGHTSPEED POS INC | 2 | Q1 2021 | 28.3% |
| None | 1 | Q3 2022 | 0.0% |
View Canaan Partners IX LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-04-28 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-07-22 |
| 13F-HR | 2021-05-03 |
| 13F-HR | 2021-02-02 |
View Canaan Partners IX LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.